We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.20 | 2.00 | 2.40 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2021 to Apr 2024
By Joe Hoppe
Omega Diagnostics Group PLC said Tuesday that technology partner Mologic Ltd. has requested an independent evaluation of its coronavirus test, but that this won't have implications for its U.K. government manufacturing contract.
The London-listed medical-diagnostics company said Mologic, its partner in developing a rapid coronavirus test, has requested research lab Porton Down evaluate its test with an independent party observing. The move comes in response to media speculation that Mologic's tests have been blocked by the U.K. government.
The company said this won't affect its contract with the Department of Health and Social Care, or DHSC. Under that contract it will use equipment loaned by the U.K. government to manufacture whichever test the DHSC approves.
Shares at 1039 GMT were down 4.5 pence, or 6.5%, at 65.0 pence. Shares fell as much as 14% earlier in the session.
Write to Joe Hoppe at joseph.hoppe@wsj.com
(END) Dow Jones Newswires
June 15, 2021 06:59 ET (10:59 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
